Coronavirus Latest News

Will India’s Covishield export halt amid coronavirus surge hurt its vaccine diplomacy?

As countries anxiously await delayed shipments of Covid-19 vaccines, India has defended its decision to halt exports of Covishield, the Oxford/AstraZeneca vaccine made by the Serum Institute of India (SII), to prioritise local demand amid a sharp rise in cases. “We have supplied more vaccines globally than have vaccinated our own people,” said India’s representative at the UN General Assembly last Friday. Since January 20, India has sent over 60 million vaccine doses to 71 countries, and only…

Read the original article at South China Morning Post

Related Articles

Back to top button